Visiopharm Corporation
Broomfield, CO Doing business as Visiopharm Corp Visiopharm Corporation
- UEI
- FHN9SNTDL424
- CAGE
- 7XWA3
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 513210 Software Publishers Primary
- SAM.gov registration date
- Physical address
- 8181 Arista Pl #100, Broomfield, CO 80021, USA
- Website
- visiopharm.com
- Founded
- 2001
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Visiopharm software services | Veterans Integrated Service Network 20 | $6,000 | |
| Phenoplex software upgrade | National Institute of Environmental Health Sciences | $46,008 | |
| Visiopharm digital pathology subscription | National Institute of Environmental Health Sciences | $68,800 | |
| Software | National Cancer Institute | $24,776 | |
| OCUS40 digital microscope | Defense Health Agency | $82,190 |
About Visiopharm Corporation
Visiopharm Corporation, operating as Visiopharm Corp, is a foreign-owned, for-profit enterprise headquartered in Broomfield, Colorado that sells precision pathology software, digital microscopy solutions, and biomarker analysis systems to federal health and research agencies exclusively as a prime contractor. The company is a wholly owned subsidiary of Danish manufacturer Visiopharm A/S and competes entirely in full-and-open procurements without set-aside designation across its federal footprint.
Visiopharm's capability portfolio centers on AI-driven digital pathology and tissue imaging software. Recent representative work includes a $30 thousand Perpetual Service Level Plan maintenance contract awarded by Veterans Integrated Service Network 20 in July 2026 supporting tissue and cell imaging analysis for posttraumatic stress disorder and traumatic brain injury research at the Puget Sound VA Health Care System, a $68.8 thousand digital pathology subscription with the National Institute of Environmental Health Sciences awarded in August 2024, a $82.2 thousand purchase order from the Defense Health Agency in September 2023 for OCUS40 digital microscopes, and a $168.6 thousand biomarker analysis system sale to Veterans Integrated Service Network 8 in May 2022 for cancer detection using PD-L1 algorithm analysis. The company derives roughly 20 years of expertise in deep learning and artificial intelligence for digital pathology according to its federal descriptions.
Customer concentration clusters tightly within the Department of Veterans Affairs and the Department of Health and Human Services. Veterans Integrated Service Network 20 leads by both award count and dollar value (5 awards, $279 thousand combined potential), followed by the National Institute of Environmental Health Sciences (4 awards, $262 thousand), and Veterans Integrated Service Network 8 ($169 thousand). The top five customers account for 83% of combined potential value across the vendor's footprint. The National Cancer Institute, the NIH Clinical Center, and the FDA round out the active customer set. All 17 recent awards are firm-fixed-price purchase orders with no parent contract vehicles; Visiopharm does not sit on GWACs, IDIQs, or BPAs.
Activity has remained modest and episodic — two awards in 2021, three in 2022, two in 2023, three in 2024, and one in 2026 — with a combined potential value of $1.1 million across all 17 prime awards and 98% of that value already obligated. Only one award carries an ultimate completion date within the next twenty-four months, creating minimal recompete exposure in that window. Visiopharm does not maintain a subcontractor footprint; all work is delivered as prime.
Quick answers
What is Visiopharm Corporation's UEI?
Visiopharm Corporation's Unique Entity ID (UEI) in SAM.gov is FHN9SNTDL424.
What is Visiopharm Corporation's CAGE code?
Visiopharm Corporation's CAGE code is 7XWA3.
What is Visiopharm Corporation's primary NAICS code?
Visiopharm Corporation's primary NAICS code is 513210 (Software Publishers).
Where is Visiopharm Corporation located?
Visiopharm Corporation's physical address in SAM.gov is 8181 Arista Pl #100, Broomfield, CO 80021, USA.
Is Visiopharm Corporation registered in SAM.gov?
Yes. Visiopharm Corporation's SAM.gov registration is active through March 2, 2027.
What is Visiopharm Corporation's most recent federal award?
Visiopharm Corporation's most recent federal contract award is Visiopharm software services (36C26026P0608), from Veterans Integrated Service Network 20, on July 25, 2026.
On GovTribe
See Visiopharm Corporation's full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors